biobusinessblog.wordpress.com
BioBusinessBlog | Insights for Investors and ExecutivesInsights for Investors and Executives
http://biobusinessblog.wordpress.com/
Insights for Investors and Executives
http://biobusinessblog.wordpress.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Wednesday
LOAD TIME
0.3 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
4
SSL
EXTERNAL LINKS
19
SITE IP
192.0.78.12
LOAD TIME
0.301 sec
SCORE
6.2
BioBusinessBlog | Insights for Investors and Executives | biobusinessblog.wordpress.com Reviews
https://biobusinessblog.wordpress.com
Insights for Investors and Executives
biobusinessblog.wordpress.com
danielteper | BioBusinessBlog
https://biobusinessblog.wordpress.com/author/danielteper
Insights for Investors and Executives. Should Pfizer buy Wyeth? January 24, 2009. Pfizer has reached the top of the pharmaceutical ladder in large part thanks to mega-acquisitions. The Warner Lambert acquisition most notably brought Lipitor which Pfizer grew into a $ 12 billion brand. The acquisition of Pharmacia brought a more diversified portfolio, although Celebrex felt to reach full blockbuster status because of post-marketing safety issues. Analysts like the Pfizer-Wyeth combination, because it stre...
BioBusinessBlog | Insights for Investors and Executives | Page 2
https://biobusinessblog.wordpress.com/page/2
Insights for Investors and Executives. Newer posts →. Is it time to buy Schering Plough stock? April 6, 2008. Shares of Schering Plough ( NYSE:SGP. And Merck and Company ( NYSE:MRK. Stressing that SGP trades at less than 10 times earnings, that the company is valued at the price of Organon plus Remicade sales, while it has another $ 15 billion in sales and the second best short term pipeline in the industry based on potential launches in the 2008-2012 period. American College of Cardiology. April 5, 2008.
Should Pfizer buy Wyeth? | BioBusinessBlog
https://biobusinessblog.wordpress.com/2009/01/24/should-pfizer-buy-wyeth
Insights for Investors and Executives. Biotech Winners of 2008 and Early 2009 Outlook. Should Pfizer buy Wyeth? January 24, 2009. Pfizer has reached the top of the pharmaceutical ladder in large part thanks to mega-acquisitions. The Warner Lambert acquisition most notably brought Lipitor which Pfizer grew into a $ 12 billion brand. The acquisition of Pharmacia brought a more diversified portfolio, although Celebrex felt to reach full blockbuster status because of post-marketing safety issues. Analysts li...
Biotech Winners of 2008 and Early 2009 Outlook | BioBusinessBlog
https://biobusinessblog.wordpress.com/2009/01/02/biotech-winners-of-2008-and-early-2009-outlook
Insights for Investors and Executives. Will the VC Liquidity Crisis put a Stop to New Venture Financing? Should Pfizer buy Wyeth? Biotech Winners of 2008 and Early 2009 Outlook. January 2, 2009. Proved to be a. With the Dow Jones Biotech Index up 4% in 2008 while the overall DJ Market Index was down 39%. The. Resisted better at -16% than the overall NASDAQ Market Index which fell 42%. No less than four Biotech companies figured among the top 10 Gainers of 2008 on Wall Street. Up 637% at $13.02. ViroPharm...
TOTAL PAGES IN THIS WEBSITE
4
Neuromics: July 2015
http://neuromics.blogspot.com/2015_07_01_archive.html
Tuesday, July 21, 2015. Neuropeptides Antagonists, Stress and Alcohol Seeking. S can help moderate stress and related Alcohol seeking behaviors. The authors of this study reference use of our ppENK. Neuropeptides: J.R. Schank,B.S. Nelson,R. Damadzic,J.D. Tapocik,M. Yao,C.E. King,K.E. Rowe,K. Cheng,K.C. Rice,M. Heili. Neurokinin-1 receptor antagonism attenuates neuronal activity triggered by stress-induced reinstatement of alcohol seeking. Doi:10.1016/j.neuropharm.2015.07.009. Links to this post. We welco...
Neuromics: April 2015
http://neuromics.blogspot.com/2015_04_01_archive.html
Sunday, April 26, 2015. Bioactive FGF Basic Recombinant Protein in Action. Maintaining Sheep Mesenchymal Stem Cell Multipotency. We have been very selective in the Bioactive FGF2 or FGF-basic Recombinant Proteins. We make available to Stem Cell Researchers. They are many options available so we are always encouraged when we see ours referenced in publications. Stem Cell Research and Therapy 2015, 6:84 doi:10.1186/s13287-015-0075-4. These cells were used for chondrogenesis studies. Links to this post.
Neuromics: May 2015
http://neuromics.blogspot.com/2015_05_01_archive.html
Friday, May 29, 2015. Neuromics' Stem Cell Markers. Potent, Proven and Published. We have a growing parade of Publications. Referencing use of our Stem Cell Markers. They have proven to be excellent for assays using our hNP1™ Human Neural Progenitor Kits. And Human Mesenchymal Stem Cells (hMSCs). Here's a recent reference highlighting use of our Nucleostemin Antibody. Figure: Expression of Nucleostemin for BMSCs (E) and MMSCs (F). I will continue to post Stem Cell Marker success stories here. I will cont...
Neuromics: August 2015
http://neuromics.blogspot.com/2015_08_01_archive.html
Friday, August 28, 2015. Small Molecules/Peptides for Pain Researchers. Agonists, Antagonists, Inhibitors and Ligands. The roots of Neuromics is providing solutions for the study of nociceptive and neuropathic pain. Our tools are widely used and frequently published. We are pleased to bring you these small molecules designed to help you better understand the roots of pain and potential therapies. 2-Methylthioadenosine triphosphate tetrasodium salt. Or 612-801-1007. Thank you! Links to this post. I have r...
Neuromics: Voices of our Customers
http://neuromics.blogspot.com/2015/06/voices-of-our-customers.html
Monday, June 22, 2015. Voices of our Customers. Your Feedback Matters-A lot. Our follow up processes include actively engaging users of our solutions for feedback and input. This includes Rose Ludescher, Manager of Customer Satisfaction, calling or sending e-mails to each user within 3 weeks of shipment. At the core is our product rating website. If users identify products related issues, we replace them or refund their purchases. We are always pleased when customers share data. E-18 Primary Rat Neurons.
Neuromics: Gene Expression-Have it Your Way
http://neuromics.blogspot.com/2015/08/gene-expression-have-it-your-way.html
Monday, August 03, 2015. Gene Expression-Have it Your Way. From Delivery to Stable Expression. Neuromics has a successful track record of helping our clients delivery siRNA, miRNA, Plasmids and other oligos in vitro and in vivo with our Transfection Kits. But my vision with our cell based assay solutions. Gene Transfer and Expression Products Leveraging the Sleeping Beauty Technology:. Images: B-MoGen Transposon exhibiting stable expression of five fluorescent genes. Labels: gene expression analysis.
Neuromics: New Human Brain Microvascular Cells
http://neuromics.blogspot.com/2015/08/new-human-brain-microvascuilar-cells.html
Saturday, August 08, 2015. New Human Brain Microvascular Cells. HBMECS for BBB Researchers. I am pleased by the growing positive response to our Human Endothelial Cells. Offerings. Our Human Brain Microvascular Endothelial Cells. Have, far and away, been the most popular. We want to make it easier for you to "buy and try" We are offering them for only 699 USD/500,000 Cells through Aug. 31st, 2015. Note: customers have passaged these cells up to 15 X. Please contact me: pshuster@neuromics.com. Take Your N...
Neuromics: Proven Stem Cell Markers and Multiple Applications
http://neuromics.blogspot.com/2015/05/proven-stem-cell-markers-and-multiple.html
Sunday, May 17, 2015. Proven Stem Cell Markers and Multiple Applications. More Bang for Your Buck! Our Stem Cell Markers. Remain a growth engine for Neuromics. One of the reasons that you would want to check out offerings are that we have selected markers that can be used in multiple applications. Being used for these two applications. ICC; IF; WB. ICC; IHC; WB; E. ICC; IHC; WB; E. IHC; WB; FC. IHC; FC; NB. FC; ICC; IF; WB. FC; ICC; IHC; WB. FC; ICC; IHC; WB. ICC; IHC; WB; E. IHC; WB; FC. ICC; IF; IHC; WB.
Neuromics: Save 100 USD on Our New Cardiomyocytes
http://neuromics.blogspot.com/2015/06/save-100-usd-on-our-new-cardiomyocytes.html
Wednesday, June 24, 2015. Save 100 USD on Our New Cardiomyocytes. Potent, Pure and Easy to Culture. I am pleased to announce the addition of Human Cardiomyocytes. To our Stem and Cell Based Assay Solutions. These cells are optimized to provide addition options for in-vitro testing of drug to drug candidate toxicities allowing researchers to rule out the ineffective and potentially toxic small molecules/compounds early in the process. On our other primary and stem cells:. Kirsten Raehal, Purdue Pharma.
TOTAL LINKS TO THIS WEBSITE
19
Hem - Biobusiness |
Så kan skogen lösa livsmedelsproblematiken. Den ekologiska skulden växer. Idag, med nästa fyra månader kvar av året är jordens resurser för i år slut. Från och med den här dagen börjar vi leva på lånade tillgångar. Marknaden för nanocellulosa allt större. Marknaden för nanocellulosa växer med 20 procent och Sverige har tätpositionen. Avfall lämpligt för torrdestilering. Efterfrågan på olja når nya rekord. UPM och Sekab samarbetar inom skogsbaserad kemi. Nanocellulosa växer 20 procent om året. Den 23 juni...
Business TV – TV Channel for Earthmoving & Construction
TV Channel for Earthmoving and Construction. Earthmoving and Construction TV. Welcome to Business TV for Earthmoving and Construction. If you can’t find a video or channel here of interest you’re not looking hard enough! Or you’ve come to the wrong site. Seriously thou, we post all sorts of interesting videos of earthmoving and civil construction, it’s what we do and love. If were not on the machines were watching videos of them 😉. Earthmoving and Dredging for a Road Construction Part2. Excavators are m...
USI - BioBusiness - Advanced short course on BioEntrepreneurship at USI
Structure and content of the program. Premio speciale della Svizzera. Article Nature on CH. This short advanced program was designed with ambitious objectives: to create an exclusive learning platform and network where academia, industry and venture capitalists interact fruitfully. We would be very pleased to welcome you to BioBusiness and Lugano! Prof Dr. Piero Martinoli. President, Università della Svizzera italiana.
BioBusiness Arena | En kraftsamling för hållbarhet
En kraftsamling för hållbarhet. Science & Innovation Day. Vi har blivit en del av Processum! Är en långsiktig satsning med målet att främja innovation av hållbara produkter och tjänster. Med bioekonomins förnyelse som grund arbetar vi strategiskt för ökad tillväxt och fler arbetstillfällen. Vad är en bioekonomi egentligen? Vill du veta mer om bioekonomin och dess betydelse? Ta gärna 2 minuter och låt dig inspireras av vad allas vår bioekonomi kan åstadkomma. Paper to replace plastic. Event och aktivitete...
Binero Webbhotell - vänligast på webben
BioBusinessBlog | Insights for Investors and Executives
Insights for Investors and Executives. Should Pfizer buy Wyeth? January 24, 2009. Pfizer has reached the top of the pharmaceutical ladder in large part thanks to mega-acquisitions. The Warner Lambert acquisition most notably brought Lipitor which Pfizer grew into a $ 12 billion brand. The acquisition of Pharmacia brought a more diversified portfolio, although Celebrex felt to reach full blockbuster status because of post-marketing safety issues. Analysts like the Pfizer-Wyeth combination, because it stre...
Biobusiness Consulting Incorporated
Biobusiness consulting incorporated provides biobanking, clinical research and biotechnology advisory and consulting services to its pharmaceutical, biotechnology, life science CRO, academic medical center, non-profit and government clients worldwide. Life science business development. Software development and evaluation. New Contact Us 2. Powered by InstantPage® from GoDaddy.com. Want one?
biobusinessgroup | Creando valor para las empresas de Chile y Latinoamérica, Creating value for the companies
Servicios I&D i. Atracción de inversiones, empresas extranjeras y proyectos de alta tecnología a Chile. Implementación de sistemas Gestión de la innovación y levantamiento de fondos (Corfo, Innova, Capital de Riesgo). Consultoría inspecciones, verificaciones. Implementación Globalgap, GMP, HACCP, ISO 22000. Sistemas de gestión. Implementación de sistemas de gestión certificables ISO 9001, ISO 14001, OHSAS 18001, ISO 17025 y sistemas integrados. Servicios I D i. Disponible kit documental ISO 9001.
Bio Business, Los Angeles, USA
Bio Business, Los Angeles, USA. Business Opportunities in Pharmaceuticals and Biotechnology Worldwide. Our objectives and beliefs can be summed up in "Value Creation through Innovation". This vision has helped us to build on our strengths and make our distinctive character. This is what drives us to continuously search for new and innovative ways to bring better health to all of us. International Investment in Healthcare. Future of Pharma, Biotech and Healthcare Industry. In future, both pharma and biote...
BioBusiness life and health sciences
Bio Business - Home
The story of the Ontario life sciences sector is one of research, innovation and entrepreneurship. The province’s high concentration of research institutions and life sciences businesses has created the ideal climate for major advances in the biotechnology and pharmaceutical spaces. We spoke to industry insiders with their fingers on the pulse to learn what makes the Ontario life sciences sector tick. MINISTER OF RESEARCH, INNOVATION AND SCIENCE. MAYOR, MISSISSAUGA, ON. These are exciting times for Bonni...
